Cargando…
Computational Design, Synthesis, and Biological Evaluation of Diimidazole Analogues Endowed with Dual PCSK9/HMG-CoAR-Inhibiting Activity
[Image: see text] Proprotein convertase subtilisin/kexin 9 (PCSK9) is responsible for the degradation of the hepatic low-density lipoprotein receptor (LDLR), which regulates circulating cholesterol levels. Consequently, the PCSK9 inhibition is a valuable therapeutic approach for the treatment of hyp...
Autores principales: | Lammi, Carmen, Fassi, Enrico M. A., Manenti, Marco, Brambilla, Marta, Conti, Maria, Li, Jianqiang, Roda, Gabriella, Camera, Marina, Silvani, Alessandra, Grazioso, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291552/ https://www.ncbi.nlm.nih.gov/pubmed/37261954 http://dx.doi.org/10.1021/acs.jmedchem.3c00279 |
Ejemplares similares
-
Computational Design and Biological Evaluation of Analogs of Lupin Peptide P5 Endowed with Dual PCSK9/HMG-CoAR Inhibiting Activity
por: Lammi, Carmen, et al.
Publicado: (2022) -
Severe Anti-HMG-CoAR Necrotizing Autoimmune Myopathy Secondary to Statin Use
por: Pulipati, Priyanjali, et al.
Publicado: (2022) -
Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
por: Brennan, Donal J, et al.
Publicado: (2010) -
HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes
por: Di Benedetto, Anna, et al.
Publicado: (2016) -
Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity
por: Fassi, Enrico Mario Alessandro, et al.
Publicado: (2022)